[Kosdaq Star] Buoyed by bio, genome sequencing pioneer Macrogen seeks stable future
IndustryJun 3, 2018
This is the 56th in a series of articles analyzing major companies traded on the tech-heavy Kosdaq market. -- Ed. Only two decades ago, today’s genome sequencing technology sounded like magic. Driven by growing interest in the mysteries of the human body and passion for finding a cure, the market for genome sequencing service market has doubled in eight years. The price of the service also plummeted significantly in the 15 years leading to 2016, giving researchers easier access cost-wise to geno